Search clinical trials for: A: OLP-1002

Total 15204 results

Chengdu SciMount Pharmatech Co., Ltd.

Completed

A Phase 1 Study of SMP-100 in Normal Healthy Volunteers

Healthy Volunteers

Australia
Protalix
Chiesi Farmaceutici S.p.A.

Completed

Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function (BALANCE)

Fabry Disease

United States, Netherlands, Hungary, United Kingdom, Czechia, Norway, Slovenia, Spain, Finland, France, Italy, Switzerland
University of Hawaii

Recruiting

Natives Engaged in Alzheimers Research - 'Ike Kupuna (NEAR)

Mild Cognitive Impairment | Subjective Cognitive Impairment

United States
Valo Health, Inc.

Withdrawn

Efficacy and Safety of OPL-0301 Compared to Placebo in Adults With Post-Myocardial Infarction (MI) (RESTORE)

Myocardial Infarction
Massachusetts General Hospital

Active, not recruiting

Neuromodulation of Mind-Wandering in Depression

Depression

United States
Neurological Associates of West Los Angeles

Enrolling by invitation

Focused Ultrasound for the Treatment of ADHD Symptoms

ADHD

United States
Quark Pharmaceuticals

Completed

A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery

Acute Kidney Injury

United States, Canada, Germany
Chiesi Farmaceutici S.p.A.
ICON plc

Recruiting

Study to Evaluate the Safety, PK, PD, and Efficacy of PRX-102 in Japanese Patients With Fabry Disease (RISE)

Fabry Disease

Japan
Quark Pharmaceuticals

Completed

QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant (ReGIFT)

Delayed Graft Function

United States, Spain, Canada, Australia, Netherlands, Germany, Belgium, France, Argentina, Brazil, Czechia
Jeil Pharmaceutical Co., Ltd.

Completed

Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers

Overactive Bladder | Benign Prostatic Hyperplasia | LUTS
Centre Hospitalier Universitaire Vaudois
Ludwig Institute for Cancer Research

Completed

Immunotherapy of Stage III/IV Melanoma Patients

Melanoma

Switzerland
National Cancer Institute (NCI)

Terminated

Oxaliplatin and Topotecan in Advance Ovarian Cancer

Recurrent Ovarian Epithelial Cancer

United States
OncoMed Pharmaceuticals, Inc.

Completed

A Dose Escalation Study of OMP-59R5 in Subjects With Solid Tumors

Solid Tumors

United States
OncoMed Pharmaceuticals, Inc.

Completed

A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors

Solid Tumors

United States
Sorbent Therapeutics
Pharmaterra

Completed

Evaluation of CLP in Heart Failure Patients With Chronic Kidney Disease

Heart Failure

Georgia, Moldova, Republic of, Armenia
Chiesi Farmaceutici S.p.A.
ICON plc

Not yet recruiting

A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease (FLY)

Fabry Disease
Zealand Pharma
Profil Institut für Stoffwechselforschung GmbH

Recruiting

A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570

Safety and Tolerability

Germany
A.T. Still University of Health Sciences
American Osteopathic Association

Withdrawn

Thoracic Lymphatic Pump Techniques for Reducing Lung Volumes in Persons With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

United States
Nestlé

Completed

Effects of Enzymatic Digestion and Probiotic on Oleuropein Bioavailability

Healthy Subjects

Spain
Wake Forest University Health Sciences

Active, not recruiting

SNIFF Multi-Device Study 2

Cognitive Impairment | Mild Cognitive Impairment

United States
Institute of Medical Biology, Chinese Academy of...
Guangxi Center for Disease Control and Prevention

Completed

A Phase II, Safety and Efficacy Study of Inactivated EV 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants

The Study Focused on the Safety of Inactivated EV71 Vaccine (Human Diploid Cell) Against Hand, Foot and Mouth Disease in Chinese Children and Infants

China
Taipei Medical University

Active, not recruiting

Effects of Bifidobacterium Longum OLP-01 Supplement on Cognitive Function, Exercise Performance, Nutritional Status and Gut Microbiota in Stroke Patients

Stroke

Taiwan
Olympus Europe SE & Co. KG
Cromsource

Recruiting

Safety and Efficacy of the Olympus CADe System in Real-time Colonoscopy (EuroCADe)

Colorectal Cancer

Germany, Spain, Belgium, Sweden
OncoMed Pharmaceuticals, Inc.

Completed

A Dose Escalation Study of OMP-52M51 in Subjects With Solid Tumors

Relapsed or Refractory Solid Tumors

United States
ProTiP Medical

Terminated

NewBreez Safety and Efficacy Evaluation

Swallowing Disorders

France, Belgium
Amedica Corporation

Completed

Valeo OL Interbody Fusion Devices for Posterior Lumbar Interbody Fusion SNAP Trial (SNAP)

Degenerative Spondylolisthesis | Disc Degeneration of Pfirrmann Grade III or Greater | Isthmic Spondylolisthesis of Grade I or II

Netherlands
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Completed

The Safety and Tolerability of STSA-1002 Following Intravenous Infusion in Healthy Subjects

Healthy

United States
Quark Pharmaceuticals

Terminated

QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery

Cardiac Surgery

United States, Germany, Spain, Australia, Austria, Canada, New Zealand, United Kingdom, Belgium, Czechia, France
Quark Pharmaceuticals

Completed

I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation

Delayed Graft Function | Other Complication of Kidney Transplant

United States, Spain, Germany, France, Canada
Quark Pharmaceuticals

Terminated

A Dose Escalation and Safety Study of I5NP to Prevent Acute Kidney Injury (AKI) in Patients at High Risk of AKI Undergoing Major Cardiovascular Surgery (QRK.004)

Acute Kidney Injury | Acute Renal Failure

United States
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Completed

The Safety of STSA-1002 Following Intravenous Infusion in Healthy Subjects

Healthy

China
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Completed

The Safety and Tolerability of STSA-1002 Following Subcutaneous Injection in Healthy Subjects

Antineutrophil Cytoplasmic Antibody Associated Vasculitis

United States
GlaxoSmithKline

Terminated

A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RRMS)

Multiple Sclerosis, Relapsing-Remitting

United Kingdom
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Completed

A Study of STSA-1002 in Healthy Subjects

Healthy Subject

China
Massachusetts General Hospital

Withdrawn

Focused Ultrasound Neuromodulation for Treatment of Temporal Lobe Epilepsy (LIFUP)

Low Intensity Ultrasound Pulsarions
Riphah International University

Recruiting

Role of Synchronized Lifestyle Modification Program on Diabetic Neuropathy Taking Oral Hypoglycemics

Diabetic Neuropathies

Pakistan
University of Maryland, Baltimore
University of Maryland, College Park

Completed

Harnessing Placebo Effects in Methadone Treatment

Opioid-Related Disorders | Opioid-use Disorder

United States
Sciwind Biosciences APAC CO Pty. Ltd.
Hangzhou Sciwind Biosciences Co., Ltd.

Completed

To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants (XW003)

Obesity | Type 2 Diabetes Mellitus | Nonalcoholic Steatohepatitis

Australia
Anthera Pharmaceuticals

Completed

FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes (FRANCIS-ACS)

Acute Coronary Syndrome

Russian Federation, Georgia, Ukraine
Zealand Pharma

Completed

A Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570

Healthy

Germany
Unicycive Therapeutics, Inc

Active, not recruiting

A Study to Assess the Tolerability of Oxylanthanum Carbonate in Patients With Chronic Kidney Disease on Dialysis

Chronic Kidney Disease Requiring Chronic Dialysis

United States
Rambam Health Care Campus

Completed

Early Detection of Pressure Induced Tissue Damage by Infrared Spectroscopy (ODP) Device

Pressure Ulcer Not Visible

Israel
Umeå University
The Swedish Research Council; Forte; Glasgow Caledonian University

Completed

A Feasibility Study of a Mobile Application Intervention to Promote Strength and Balance Exercises in Older People

Accidental Falls

Sweden
M.D. Anderson Cancer Center

Completed

Compassionate Use of Brontictuzumab for Adenoid Cystic Carcinoma (ACC)

Adenoid Cystic Carcinoma

United States
Novavax
Department of Health and Human Services

Completed

A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 1

Influenza (Pandemic)

United States
NHS Tayside

Terminated

AuraGain and iGel Crossover Comparison

Airway Management | Laryngeal Mask Airway

United Kingdom
Medicago
Syneos Health

Completed

Immunogenicity, Safety, Tolerability of a Plant-Made H5 VLP Influenza Vaccine

RNA Virus Infections | Virus Diseases | Respiratory Tract Infections | Respiratory Tract Diseases

Canada
University Hospital Tuebingen

Terminated

Safety and Drug Absorption of Orally Administered Oleylphosphocholine (OlPC) in Healthy Adults

Leishmaniasis

Germany
Optimal Health Research

Completed

A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome (PLDS)

Post-Lyme Disease Syndrome (PLDS)

United States
OncoMed Pharmaceuticals, Inc.

Completed

A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid Tumors

Solid Tumors

United States

Search clinical trials for: A: OLP-1002

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations